<p>a] Serum deprived HaCaT cells were treated with areca nut (5H; 5 μg/ml) with or without ALK5 inhibitor (10 μM of SB 431542) as described in material and methods. Expression of TGF-β and its activator THBS1 was analyzed by qPCR. Areca nut induced TGF-β and THBS1 which was compromised by ALK5inhibitor (SB 431542) P values ≤0.0001, ≤0.001, ≤0.01 are depicted as *** ** and * respectively. b] Serum deprived hGF cells were treated with areca nut and TGF-β (5H; 5 μg/ml; 10H; 10 μg/ml; TGF-β; T; 5 ng/ml). Expression of TGF-β ligands and receptor isoforms were assessed by semi quantitative PCR. Areca nut treatment did not induce TGF-β ligands and receptor isoforms. TGF-β treatment induced TGF-β1 isoform in hGF cells.</p
Areca nut consumption has been implicated in the progression of Oral Submucous fibrosis (OSF); an in...
<p>Gene Set Enrichment analysis of differentially regulated genes in hGF cells by areca nut and TGF-...
Oral submucous fibrosis (OSF) is potentially premalignant with progressive and irreversible extracel...
<p>A & B] Areca nut induced genes by Western blot and by qRT-PCR. HaCaT cells were serum starved for...
<p>Treatment of HaCaT cells with both the Alkaloid and Polyphenol fractions of areca nut water extra...
<p>To study the epithelial mesenchymal interaction, confluent cultures of HaCaT cells were serum sta...
<p>Serum starved hGF cells were treated with areca nut water extract (5H; 5 μg/ml), TGF-β (T; 5 ng/m...
<p>Human keratinocytes (HaCaT) cells were serum deprived for 24 hours and treated with areca nut ext...
<p>Condition medium of HaCaT cells treated with areca nut with or without ALK5 inhibitor; SB 431542 ...
<p>a] Venn diagram representing differentially regulated genes by areca nut and/or TGF-β in hGF cell...
Oral submucous fibrosis (OSF) is a chronic inflammatory disease characterized by the accumulation of...
<div><p>Oral submucous fibrosis (OSF) is a chronic inflammatory disease characterized by the accumul...
Oral submucous fibrosis (OSF) is a chronic inflammatory disease characterized by the accumulation of...
<p>Areca nut can induce and activate TGF-β in epithelial cells which can act together on the fibrobl...
Areca nut consumption has been implicated in the progression of Oral Submucous fibrosis (OSF); an in...
Areca nut consumption has been implicated in the progression of Oral Submucous fibrosis (OSF); an in...
<p>Gene Set Enrichment analysis of differentially regulated genes in hGF cells by areca nut and TGF-...
Oral submucous fibrosis (OSF) is potentially premalignant with progressive and irreversible extracel...
<p>A & B] Areca nut induced genes by Western blot and by qRT-PCR. HaCaT cells were serum starved for...
<p>Treatment of HaCaT cells with both the Alkaloid and Polyphenol fractions of areca nut water extra...
<p>To study the epithelial mesenchymal interaction, confluent cultures of HaCaT cells were serum sta...
<p>Serum starved hGF cells were treated with areca nut water extract (5H; 5 μg/ml), TGF-β (T; 5 ng/m...
<p>Human keratinocytes (HaCaT) cells were serum deprived for 24 hours and treated with areca nut ext...
<p>Condition medium of HaCaT cells treated with areca nut with or without ALK5 inhibitor; SB 431542 ...
<p>a] Venn diagram representing differentially regulated genes by areca nut and/or TGF-β in hGF cell...
Oral submucous fibrosis (OSF) is a chronic inflammatory disease characterized by the accumulation of...
<div><p>Oral submucous fibrosis (OSF) is a chronic inflammatory disease characterized by the accumul...
Oral submucous fibrosis (OSF) is a chronic inflammatory disease characterized by the accumulation of...
<p>Areca nut can induce and activate TGF-β in epithelial cells which can act together on the fibrobl...
Areca nut consumption has been implicated in the progression of Oral Submucous fibrosis (OSF); an in...
Areca nut consumption has been implicated in the progression of Oral Submucous fibrosis (OSF); an in...
<p>Gene Set Enrichment analysis of differentially regulated genes in hGF cells by areca nut and TGF-...
Oral submucous fibrosis (OSF) is potentially premalignant with progressive and irreversible extracel...